Latin America In Vitro Diagnostics Market

The report "Latin America In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Disease) - Forecast to 2031" is expected to grow from an estimated USD 5.87 billion in 2026 to reach USD 8.13 billion by 2031, at a CAGR of 6.7% during the forecast period.

Browse 120 market data Tables and 44 Figures spread through 200 Pages and in-depth TOC on "Title"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/latin-america-in-vitro-diagnostics-market-112168050.html

As disease surveillance efforts increase due to a rise in infectious and chronic diseases in the region, the IVD market in Latin America is experiencing growth. Growing concerns about monitoring disease patterns and improving public health responses have led to a higher demand for diagnostic testing. Additionally, enhanced access to health services is enabling a larger portion of the population to undergo routine and follow-up testing. Together, these factors are driving sustained growth in the utilization of diagnostics across the region.

The laboratory tests segment led the LATAM IVD market in 2025, by site of testing.

On the basis of the site of testing, the Latin America in vitro diagnostics market has been classified into laboratory tests and POCT. Of the two, the laboratory tests segment accounts for a larger share of the market. The growing number of laboratories handling diverse and complex testing is enhancing the position of the laboratory testing segment in the market. Their capacity to provide accurate results, process multiple samples, and perform advanced testing is contributing to this dominance.

The molecular diagnostics segment is expected to register the fastest growth during the forecast period.

The Latin American in vitro diagnostics market is categorized into various segments, including immunoassays, clinical chemistry, and blood glucose monitoring. Other segments include hematology, microbiology, coagulation & hemostasis, blood gas analyzers, urinalysis, and chromatography and mass spectrometry. Among these, molecular diagnostics is expected to be the fastest-growing segment. This growth is driven by the increasing demand for accurate and rapid detection of infectious diseases, the rising use of genetic and oncology testing, and the growing adoption of advanced molecular platforms in hospitals, clinics, clinical laboratories, and other healthcare settings.

The major players operating in this market are F. Hoffmann-La Roche Ltd. (Switzerland), Abbott (US), Danaher (US), Siemens Healthineers AG (Germany), bioMérieux (France), Thermo Fisher Scientific Inc. (US), QuidelOrtho Corporation (US), Illumina, Inc. (US), Becton, Dickinson and Company (US), and Agilent Technologies, Inc. (US).

Don’t miss out on business opportunities in Keyword. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com